Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-03

Clinical Trial Update: The RESPLASH Study [NA]

View source ↗

Summary

This is an update on the RESPLASH clinical trial (NCT06880562) sponsored by Tulane University investigating resistant hypertension. The study status is NOT_YET_…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Tulane University | Conditions: Resistant Hypertension | NA | Status: NOT_YET_RECRUITING